IL-17-producing cells of both lymphocytic and myeloid origins or the microenvironment of the cancer cell as well as their suggested pro- and antitumorigenic functions in an organ-dependent context all contribute to make it purely a challenge to bring science to clinical practice (75). Here, IL17A is linked to cancer.